Sequent Scientific Limited has informed the Exchange about Shareholders meeting
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sequent Scientific Limited has informed the exchanges that the NCLT Hyderabad Bench has ordered separate meetings of equity shareholders and unsecured trade creditors on Saturday, August 30, 2025, to consider a Composite Scheme of Amalgamation. The scheme involves 10 entities: Sequent Scientific, Symed Labs, Vandana Life Sciences, Appcure Labs, Vindhya Pharma, S.V. Labs, Vindhya Organics, Viyash Life Sciences, Geninn Life Sciences, and Sequent Research. The equity shareholders' meeting is at 10:00 a.m. IST and the unsecured creditors' meeting is at 11:00 a.m. IST, both via video conferencing. Remote e-voting via NSDL will run from 9:00 a.m. on August 26 to 5:00 p.m. on August 29, 2025. Notices were dispatched electronically on July 28, 2025, and the company has engaged NSDL to provide the e-voting facility.
This is a procedural milestone toward a major consolidation involving Sequent Scientific and multiple related entities. Shareholders and creditors should review the scheme documents and participate in the vote, as approval would advance the proposed amalgamation and could reshape the company's structure and shareholder base.